Toda, Masataro
Fujii, Kentaro
Yoshifuji, Ayumi http://orcid.org/0000-0001-8246-8675
Kondo, Yasushi
Itoh, Kazuto
Sekine, Kazuhiko
Kikuchi, Takahide
Ryuzaki, Munekazu
Article History
Received: 8 July 2021
Accepted: 16 August 2021
First Online: 26 August 2021
Declarations
:
: All the authors have declared no competing interest.
: The research ethics committee of the Tokyo Saiseikai Central Hospital evaluated and approved the study protocol (Approval Number 2021-007-01). All patients gave their written informed consent to off-label use of Tocilizumab.
: Informed consent to off-label use of Tocilizumab was obtained from all individual participants included in the study.”